TRIP-Br: a Novel Family of PHD Zinc Finger- and Bromodomain-interacting Proteins That Regulate the Transcriptional Activity of E2F-1/DP-1

Overview

Journal EMBO J

Specialties Biotechnology
Molecular Biology

Date 2001 May 2

PMID 11331592

Citations 44

Authors

S I Hsu

C M Yang

K G Sim

D M Hentschel

E OLeary

J V Bonventre

Affiliations

Soon will be listed here.

Abstract

We report the isolation of TRIP-Br1, a transcriptional regulator that interacts with the PHD-bromodomain of co-repressors of Krüppel-associated box (KRAB)-mediated repression, KRIP-1(TIF1beta) and TIF1alpha, as well as the co-activator/adaptor p300/CBP. TRIP-Br1 and the related protein TRIP-Br2 possess transactivation domains. Like MDM2, which has a homologous transactivation domain, TRIP-Br proteins functionally contact DP-1, stimulating E2F-1/DP-1 transcriptional activity. KRIP-1 potentiates TRIP-Br protein co-activation of E2F-1/DP-1. TRIP-Br1 is a component of a multiprotein complex containing E2F-1 and DP-1. Co-expression of the retinoblastoma gene product (RB) abolishes baseline E2F-1/DP-1 transcriptional activity as well as TRIP-Br/KRIP-1 co-activation, both of which are restored by the adenovirus E1A oncoprotein. These features suggest that TRIP-Br proteins function at E2F-responsive promoters to integrate signals provided by PHD- and/or bromodomain- containing transcription factors. TRIP-Br1 is identical to the cyclin-dependent kinase 4 (cdk4)-binding protein p34(SEI-1), which renders the activity of cyclin D/cdk4 resistant to the inhibitory effect of p16(INK4a) during late G(1). TRIP-Br1(p34(SEI-1)) is differentially overexpressed during the G(1) and S phases of the cell cycle, consistent with a dual role for TRIP-Br1(p34(SEI-1)) in the regulation of cell cycle progression through sequential effects on the transcriptional activity of E2F-responsive promoters during G(1) and S phases.

Citing Articles

TARANIS Interacts with VRILLE and PDP1 to Modulate the Circadian Transcriptional Feedback Mechanism in .

Akpoghiran O, Afonso D, Zhang Y, Koh K J Neurosci. 2024; 44(5).

PMID: 38296648 PMC: 10860567. DOI: 10.1523/JNEUROSCI.0922-23.2023.

Regenerative growth is constrained by brain tumor to ensure proper patterning in Drosophila.

Abidi S, Hsu F, Smith-Bolton R PLoS Genet. 2023; 19(12):e1011103.

PMID: 38127821 PMC: 10769103. DOI: 10.1371/journal.pgen.1011103.

Molecular Mechanism of PP2A/B55α Phosphatase Inhibition by IER5.

Cao R, Jones D, Pan L, Yang A, Wang S, Padi S bioRxiv. 2023; .

PMID: 37693604 PMC: 10491241. DOI: 10.1101/2023.08.29.555174.

Inhibitory role of TRIP-Br1 oncoprotein in anticancer drug-mediated programmed cell death via mitophagy activation.

Jung S, Myagmarjav D, Jo T, Lee S, Han S, Quynh N Int J Biol Sci. 2022; 18(9):3859-3873.

PMID: 35813469 PMC: 9254482. DOI: 10.7150/ijbs.72138.

Sequential actions of EOMES and T-BET promote stepwise maturation of natural killer cells.

Zhang J, Le Gras S, Pouxvielh K, Faure F, Fallone L, Kern N Nat Commun. 2021; 12(1):5446.

PMID: 34521844 PMC: 8440589. DOI: 10.1038/s41467-021-25758-2.

References

Schulman B, Lindstrom D, Harlow E . Substrate recruitment to cyclin-dependent kinase 2 by a multipurpose docking site on cyclin A. Proc Natl Acad Sci U S A. 1998; 95(18):10453-8. PMC: 27915. DOI: 10.1073/pnas.95.18.10453. View

Chang C, Chen Y, Lee S . Coactivator TIF1beta interacts with transcription factor C/EBPbeta and glucocorticoid receptor to induce alpha1-acid glycoprotein gene expression. Mol Cell Biol. 1998; 18(10):5880-7. PMC: 109174. DOI: 10.1128/MCB.18.10.5880. View

Deloukas P, Schuler G, Gyapay G, Beasley E, Soderlund C, Hui L . A physical map of 30,000 human genes. Science. 1998; 282(5389):744-6. DOI: 10.1126/science.282.5389.744. View

Ornaghi P, Ballario P, Lena A, Gonzalez A, Filetici P . The bromodomain of Gcn5p interacts in vitro with specific residues in the N terminus of histone H4. J Mol Biol. 1999; 287(1):1-7. DOI: 10.1006/jmbi.1999.2577. View

Dhalluin C, Carlson J, Zeng L, He C, Aggarwal A, Zhou M . Structure and ligand of a histone acetyltransferase bromodomain. Nature. 1999; 399(6735):491-6. DOI: 10.1038/20974. View

Kaelin Jr W, Pallas D, DeCaprio J, Kaye F, Livingston D . Identification of cellular proteins that can interact specifically with the T/E1A-binding region of the retinoblastoma gene product. Cell. 1991; 64(3):521-32. DOI: 10.1016/0092-8674(91)90236-r. View

Huang P, Jones R, Haskell K, Vuocolo G, Hanobik M, Huber H . Cloning of cDNAs for cellular proteins that bind to the retinoblastoma gene product. Nature. 1991; 352(6332):251-4. DOI: 10.1038/352251a0. View

Goddard A, Borrow J, Freemont P, Solomon E . Characterization of a zinc finger gene disrupted by the t(15;17) in acute promyelocytic leukemia. Science. 1991; 254(5036):1371-4. DOI: 10.1126/science.1720570. View

Qin X, Chittenden T, Livingston D, Kaelin Jr W . Identification of a growth suppression domain within the retinoblastoma gene product. Genes Dev. 1992; 6(6):953-64. DOI: 10.1101/gad.6.6.953. View

10.

Momand J, Zambetti G, Olson D, George D, Levine A . The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation. Cell. 1992; 69(7):1237-45. DOI: 10.1016/0092-8674(92)90644-r. View

11.

Kaelin Jr W, Krek W, Sellers W, DeCaprio J, Ajchenbaum F, Fuchs C . Expression cloning of a cDNA encoding a retinoblastoma-binding protein with E2F-like properties. Cell. 1992; 70(2):351-64. DOI: 10.1016/0092-8674(92)90108-o. View

12.

Cheng J, Godwin A, Bellacosa A, Taguchi T, Franke T, Hamilton T . AKT2, a putative oncogene encoding a member of a subfamily of protein-serine/threonine kinases, is amplified in human ovarian carcinomas. Proc Natl Acad Sci U S A. 1992; 89(19):9267-71. PMC: 50107. DOI: 10.1073/pnas.89.19.9267. View

13.

Sugimoto M, Nakamura T, Ohtani N, Hampson L, Hampson I, Shimamoto A . Regulation of CDK4 activity by a novel CDK4-binding protein, p34(SEI-1). Genes Dev. 1999; 13(22):3027-33. PMC: 317153. DOI: 10.1101/gad.13.22.3027. View

14.

Grieco F, Hay J, Hull R . An improved procedure for the purification of protein fused with glutathione S-transferase. Biotechniques. 1992; 13(6):856-8. View

15.

Girling R, Partridge J, Bandara L, Burden N, Totty N, Hsuan J . A new component of the transcription factor DRTF1/E2F. Nature. 1993; 362(6415):83-7. DOI: 10.1038/362083a0. View

16.

Lam E, Watson R . An E2F-binding site mediates cell-cycle regulated repression of mouse B-myb transcription. EMBO J. 1993; 12(7):2705-13. PMC: 413519. DOI: 10.1002/j.1460-2075.1993.tb05932.x. View

17.

Helin K, Wu C, Fattaey A, Lees J, Dynlacht B, Ngwu C . Heterodimerization of the transcription factors E2F-1 and DP-1 leads to cooperative trans-activation. Genes Dev. 1993; 7(10):1850-61. DOI: 10.1101/gad.7.10.1850. View

18.

Cress W, Johnson D, Nevins J . A genetic analysis of the E2F1 gene distinguishes regulation by Rb, p107, and adenovirus E4. Mol Cell Biol. 1993; 13(10):6314-25. PMC: 364690. DOI: 10.1128/mcb.13.10.6314-6325.1993. View

19.

Helin K, Harlow E, Fattaey A . Inhibition of E2F-1 transactivation by direct binding of the retinoblastoma protein. Mol Cell Biol. 1993; 13(10):6501-8. PMC: 364709. DOI: 10.1128/mcb.13.10.6501-6508.1993. View

20.

Witzgall R, OLeary E, Leaf A, Onaldi D, Bonventre J . The Krüppel-associated box-A (KRAB-A) domain of zinc finger proteins mediates transcriptional repression. Proc Natl Acad Sci U S A. 1994; 91(10):4514-8. PMC: 43816. DOI: 10.1073/pnas.91.10.4514. View